🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these profiles privately for source information, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and chemists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to users administering products of uncertain source.

Several experts stated the popularity for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Platform Response and Material Elimination

Based on TikTok, the platform has removed problematic content and prohibited associated hashtags and query recommendations. The company stated it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.

Digital Marketplace Operations

Research also found groups with up to nine thousand members marketing retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of members, populated with photos of weight loss, glowing reviews and detailed guides for preparing or administering at home.

Within minutes of entering one group, a seller shared contact information, where the majority of purchases occur. The seller sent an instruction manual and promised delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Item Information and Costs

Inside these communities, posts show dark colored parcels with postal service labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When questioned how much time a pen should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A representative for Telegram stated it regularly monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they cannot confirm. Even if the research behind this drug is sound, these online products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her staff has previously encountered individuals injured by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject users to potentially significant health risks”.